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Research in context 
Evidence before this study 
We searched PubMed for articles published in the previous 5 years (on August 24, 2016) for 
the terms ((“schizophrenia” OR “psychosis” OR “psychotic”) AND (“child” or “adolescent”) 
AND (“antecedents” OR “genetic” OR “polygenic risk scores”) and ("review")); no language 
restrictions were imposed. We identified two reviews of childhood antecedents to adult 
mental health including schizophrenia. High-risk follow-up, retrospective and population 
studies have observed that although schizophrenia onset typically occurs after puberty, illness 
is commonly preceded by observable childhood neurodevelopmental impairments that can 
also be viewed as traits in the general population. Schizophrenia genetic liability, as indexed 
by polygenic risk scores, has been found to contribute to post-pubertal mental health 
problems. 
Added value of this study 
This study adds value to previous findings in suggesting that schizophrenia genetic liability, 
indexed by genetic risk scores that were generated from a sample of adults with the disorder, 
impacts upon childhood neurodevelopment, emotional problems and behavior in the general 
population as early as age 4 years.  
Implications of all the available evidence 
Schizophrenia polygenic risk scores are associated with elevated levels of 
neurodevelopmental and mental health problems in the general population from early 
childhood to adult life. Schizophrenia genetic risk may manifest as symptoms that do not 
resemble psychosis.
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Abstract.  
Background. Schizophrenia typically onsets after puberty but is commonly preceded by 
observable childhood neurodevelopmental impairments. It is unknown if these childhood 
antecedents index genetic liability. We used polygenic risk scores (PRS) derived from a 
patient discovery sample as indicators of schizophrenia genetic liability. Our aim was to 
identify the early childhood manifestations of this liability in a UK population-based cohort.  
Method. Data were primarily analyzed using regression-based analyses in the Avon 
Longitudinal Study of Parents and Children (ALSPAC). PRS were generated from a 
published Psychiatric Genomics Consortium genome-wide association study. Outcomes were 
childhood (age 4-9 years) dimensional measures in four developmental domains (12 
indicators were explored): cognition/learning, social/communication, emotion/mood 
regulation and behavior (N=5100-6952).  
Outcomes. At age 7-9 years schizophrenia PRS showed associations with lower performance 
IQ (β=-0·056, OR=1.13), poorer social understanding (β=-0·032, OR=1·06), worse language 
intelligibility/fluency (β=-0·032, OR=1·10), irritability (β=0·032, OR=1·07) and headstrong 
behavior (β=0·031, OR=1·08). Schizophrenia PRS also predicted social and behavioral 
impairments as early as age 4 years.  
Interpretation. Childhood cognitive, social, behavioral and emotional impairments, 
implicated as antecedents to schizophrenia in high-risk, developmental studies, may represent 
early manifestations of genetic liability.  
Funding. This work was supported by the Medical Research Council (MR/M012964/1). 
 
Keywords: ALSPAC; Child; Schizophrenia; Genetics.
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 Schizophrenia risk alleles are associated with neurodevelopmental outcomes in 
childhood 
 
Many mental disorders have pre-pubertal origins (1). Although  schizophrenia typically 
onsets after puberty (1, 2), high-risk, longitudinal and retrospective studies show that full-
blown disorder is commonly preceded by impairments that manifest earlier in development 
(1). Childhood neurodevelopmental impairments involving cognition/learning, 
social/communication difficulties, emotion/mood dysregulation and behavior problems are 
known to predate the onset of schizophrenia (1-3), but it is not yet known whether these 
childhood antecedents index genetic liability for the disorder (1). 
Schizophrenia is highly heritable; although its genetic architecture is not fully resolved, a 
substantial amount of the genetic variance is explained by common risk alleles (minor allele 
frequency ≥1%)(4). Composite polygenic risk scores (PRS), derived from these risk alleles 
are now considered useful indices of genetic liability (5) and provide biologically valid 
indicators of disease risk for research (6). Moreover, there is emerging evidence that 
schizophrenia PRS predict cognitive ability and post-pubertal psychopathology including 
negative symptoms, but not psychotic-like symptoms, in the general population (7). Thus, 
before the typical age of illness onset, schizophrenia genetic liability may manifest as 
symptoms that do not resemble psychosis. Identifying the impact of schizophrenia risk alleles 
on pre-pubertal, developmental characteristics in population-based samples may help to 
identify and better understand the early origins of this disorder and the initial manifestations 
of genetic liability. 
This study set out to investigate the relationships between genetic risk for schizophrenia, as 
indexed by PRS, and pre-pubertal developmental impairments assessed at ages 7-9 years in a 
large population-based cohort. We focused on developmental domains that have previously 
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been implicated in the antecedent literature for schizophrenia (1-3): (a) cognition and 
learning, (b) social/communication problems, (c) emotion/mood dysregulation and (d) 
behavior difficulties. The aim of this study was to test the hypothesis that schizophrenia 
genetic liability impacts on early childhood development across these domains (and that they 
thus represent trait liabilities) in a population-based birth cohort, the Avon Longitudinal 
Study of Parents and Children (ALSPAC). We also investigated whether associations 
extended to an earlier age (age 4). We hypothesized that schizophrenia PRS, a disorder 
considered by many as neurodevelopmental in origin, would impact on all of the pre-pubertal 
domains that in high-risk samples have been reported to be “antecedent features”. 
 
Method 
ALSPAC sample 
The Avon Longitudinal Study of Parents and Children is a well-established prospective, 
longitudinal birth cohort study. The enrolled core sample consisted of 14,541 mothers living 
in Avon, England, who had expected delivery dates of between 1st April 1991 and 31st 
December 1992. Of these pregnancies 13,988 children were alive at 1 year. When the oldest 
children were approximately 7 years of age, an attempt was made to bolster the initial sample 
with eligible cases who had failed to join the study originally, resulting in an additional 713 
children being enrolled. The resulting total sample size of children who were alive at 1 year 
was N=14,701. Ethical approval for the study was obtained from the ALSPAC Ethics and 
Law Committee and the Local Research Ethics Committees. Following quality control, 
genotype data were available for 8365 children. Phenotype data were available for between 
5100-6952 individuals depending on the measures. Full details of the study, measures and 
sample can be found elsewhere (8, 9) (see http://www.bris.ac.uk/alspac/researchers/data-
access/data-dictionary and the online data supplement).  
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Polygenic risk scores 
Genotyping details, as well as full methods for generating the PRS, are given in the online 
data supplement. In brief, PRS were generated as the weighted mean number of disorder risk 
alleles in approximate linkage equilibrium (R2<0·25), defined in previously published 
GWAS, using standard procedures (6). In ALSPAC these were derived from dosage data of 
1,813,169 imputed autosomal SNPs (see the online data supplement for imputation details). 
Risk alleles were identified as those associated with case-status in the Psychiatric Genetic 
Consortium (PGC) analyses (35,476 cases and 46,839 controls) 
(https://www.med.unc.edu/pgc/results-and-downloads) (4) at a threshold of p<0·05, as this 
threshold maximally captures phenotypic variance for this disorder (4). Associations across a 
range of p-thresholds are shown in Figure S1 in the online data supplement. 
Phenotypic data - outcome variables 
Primary outcome variables were assessed at ages 7-9 years. Descriptive information, 
including correlations between variables, is included in the online data supplement Table S1.  
1) Cognition and learning included: a) inattention, b) reading ability, c) verbal IQ, and d) 
performance IQ. Inattention was assessed using nine ADHD items from the parent-rated 
Development and Well-Being Assessment (DAWBA; 10), a structured diagnostic assessment 
widely used in child mental health surveys (individual item range 0-2). Reading ability was 
measured using the Wechsler Objective Reading Dimensions (11) and verbal/performance IQ 
using the Wechsler Intelligence Scale for Children (12); these were standardized using a Z-
score transformation. 
2) Social/communication included: a) social understanding, b) language intelligibility and 
fluency, and c) pragmatic language. Social understanding was measured by four items from 
the Social and Communication Disorders Checklist (SCDC; 13, 14) (possible range 0-8; 
reverse scored - higher scores indicate greater social understanding). Measures of 
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intelligibility/fluency and pragmatic language were derived from the Children’s 
Communication Checklist (CCC; 15), and were comprised of 11 and 38 items respectively 
(possible ranges 16-38 and 86-162).  
3) Emotion/mood regulation was assessed using the DAWBA. Scores were computed for: a) 
irritability, which included temper tantrums, being touchy/easily annoyed and being angry 
and resentful (16), and b) anxiety, composed by summing six generalized anxiety items. 
4) Behavior included observable behaviors: a) headstrong behavior, b) aggression, and c) 
activity/impulsiveness, all measured by DAWBA items. Headstrong items included arguing 
with grown-ups, ignoring rules/refusing to do as told, doing things to annoy other people on 
purpose and blaming others for his/her own mistakes/bad behavior (16). Aggression included 
starting fights and bullying/threatening people. Activity/impulsiveness was measured by nine 
DAWBA ADHD items. 
 Age 4 years  
DAWBA data were not collected prior to age 7 years but related questionnaire measures were 
available at age 4 years. The Strengths and Difficulties Questionnaire (SDQ; 17) is a brief, 
widely used questionnaire designed to assess different domains of children’s mental health. It 
was completed by parents when children were aged 4. SDQ data were also available at age 7 
years and are presented in the supplementary material to allow comparison across ages using 
the same measure. The subscales (each comprising 5 items, individual item range 0-2) 
included prosocial behavior (e.g. considerate of other people's feelings), emotional problems 
(e.g. many worries) and conduct (behavior) problems (e.g. often lies or cheats). The conduct 
problems subscale includes an irritability item (temper tantrums), which was analyzed 
separately as this has been found to be an indicator of emotion/mood dysregulation (e.g. see 
16). All descriptive information is included in the online data supplement and Table S2, with 
associations with primary measures in Table S3. 
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Statistical analysis 
Initial univariate regression analyses involved one predictor (schizophrenia PRS) and 
multiple dimensional outcomes (12 phenotypic measures within the 4 domains).  We used a 
false discovery rate (18) to correct for multiple testing in our primary analyses using R (19). 
Given that our phenotypic measures are correlated, traditional methods of correcting for 
multiple testing, such as the Bonferroni method, would be overly conservative (20). Analyses 
were conducted in Mplus using a robust maximum likelihood parameter estimator and full 
information maximum likelihood estimation where data were present for at least one outcome 
variable (21). We also generated odds ratios for dichotomized versions of the outcome 
indicators (≥1 symptom for DAWBA and bottom 10% for reading, IQ, and 
social/communication variables, in line with previous work (e.g. 7) (percentages in each 
category are given in Supplementary Table 1). 
We further considered the possibility of potential confounders (child gender, social class); the 
sample is ancestrally homogeneous (see supplementary material). 
 
Role of the funding source 
The study sponsor played no role in the study design or collection, analysis, and 
interpretation of data, writing of the report or decision to submit the paper for publication. 
 
Results 
 
Univariate associations for age 7-9 phenotypes are shown in Table 1. In the 
cognition/learning domain we observed an association between schizophrenia PRS and lower 
performance IQ, but not with inattention, reading or verbal IQ. Within the 
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social/communication domain, we observed associations with poorer social understanding 
and lower language intelligibility/fluency, but not with pragmatic language. Within the 
emotion/mood regulation domain we observed an association between schizophrenia PRS 
and irritability, but not with anxiety. Within the behavior domain, we found an association 
specifically with headstrong behavior, but not with aggression or activity/impulsivity. These 
associations with schizophrenia PRS were significant after correcting for multiple testing and 
false discovery rate adjusted p-values are reported in Table 1.  
When controlling for child gender and social class, associations with schizophrenia PRS 
remained for performance IQ, intelligibility/fluency and headstrong behavior, but not for 
social understanding or irritability (see discussion and Supplementary Table S5). 
Effect sizes were in keeping with previous findings for PRS in epidemiological research (7, 
22); adopting the approach used by Kendler (23), we estimated that individuals in the top 
2·5% for schizophrenia PRS would be at roughly a 12-26% increased risk of high versus low 
scores for the different phenotypes.  
 
Table 2 shows the results of secondary analyses which examined associations between 
schizophrenia PRS and age 4 SDQ outcomes. Associations with schizophrenia PRS were 
found for social difficulties  and behavior problems, but not for emotion/mood regulation. At 
age 7 years, findings for the SDQ sub-scales were similar to those for the DAWBA data with 
associations observed for social difficulties, emotion/mood regulation and behavior problems, 
presented in the online data supplement Table S4.  
 
Discussion 
This study set out to investigate the relationship between schizophrenia risk alleles, as 
indexed by PRS derived from a sample of patients with disorder, and pre-pubertal 
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developmental impairments in a population-based sample of children. The clinical 
manifestations of schizophrenia are typically post-pubertal, but the disorder is considered by 
many to have a strong neurodevelopmental component and to be preceded by developmental 
deficits. It has not been known whether these early childhood difficulties (retrospectively 
recalled by those with schizophrenia and observed in high-risk studies [e.g. offspring of 
parents with schizophrenia]), are early manifestations of genetic liability.  In this population-
based sample, schizophrenia PRS showed associations with pre-pubertal performance IQ, 
social/communication difficulties, emotion/mood dysregulation and behavior problems.  
Cognitive, language and social impairments as well as emotional and behavioral difficulties 
have been well documented in children who went on to develop schizophrenia in high-risk 
follow-up, case-control and follow-back studies (1, 3). However, the majority of children 
who show such deficits do not later develop disorder, and whether these are indicators of 
genetic liability has been questioned (1). Our work suggests that pre-pubertal lower 
performance IQ, poorer social understanding and language intelligibility/fluency, irritability 
and headstrong behavior, may be early manifestations of schizophrenia genetic liability. This 
now requires testing. Our results also highlight that schizophrenia PRS contribute to traits 
that are observable in the general population from a very early age, many years before the 
onset of any adult forms of psychopathology per se. Given that the prevalence of 
schizophrenia in the general population is low, the findings suggest that these pre-pubertal 
features represent indices of liability rather than an illness prodrome.  
 
Regarding the specific developmental domains, we found evidence of association with 
schizophrenia genetic risk scores for performance IQ. Other measures of cognitive ability 
were not available, although genetic overlap between schizophrenia and pre-pubertal 
performance IQ specifically has been identified by previous work (24). Our work extends 
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these findings by suggesting that links are not generalized to other aspects of 
cognition/learning including inattention, reading and verbal IQ (that are predicted by ADHD 
PRS despite ADHD genetic discovery samples being much smaller and thus less well 
powered than those for schizophrenia (22)).  
Schizophrenia risk was also associated with social/communication difficulties as early as age 
4. Social impairments and communication skills have received less attention than cognitive 
features as possible early antecedents of mental disorders. Interestingly some of these 
social/communication difficulties could be regarded as similar to negative symptoms of 
schizophrenia that show post-pubertal associations with schizophrenia PRS (7). Our findings 
suggest that these domains of development that impact on early socialization, such as 
prosocial behavior, may also be manifestations of genetic liability to schizophrenia. 
While childhood emotional problems are most commonly considered precursors to mood 
disorders, a recent review suggests schizophrenia spectrum disorders are preceded by 
emotional problems in middle childhood (25) and recent evidence has found an association 
between schizophrenia genetic risk scores and post-pubertal anxiety disorder at age 16 in the 
general population (7). Our findings were mixed for emotional problems; associations were 
observed for irritability but not for our diagnostic measure of generalized anxiety symptoms. 
Associations between schizophrenia PRS and behavioral problems were also found as early 
as age 4. While behavioral problems are often considered largely environmentally driven, our 
finding is consistent with a neurodevelopmental component to early-onset behavioral 
problems (26), which for some may index genetic liability to adult onset mental disorders. 
 
Our findings should be considered in light of some limitations. First, while our four 
developmental domains were conceptually selected a priori based on the antecedent literature 
(1-3), our analysis involved multiple testing, and although we attempted to adjust for this, we 
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cannot rule out false positive findings and replication is advisable for any genetic finding. In 
addition, our outcome variables are inter-correlated. Further investigation into the genetic 
correlation between the different childhood traits we have identified as associated with 
schizophrenia PRS will be important to test in the future (e.g. 27). 
Another limitation is that DAWBA data, cognitive and language data were not available 
before the age of 7 years.  Correlations between primary (interview) and secondary 
(questionnaire) measures in ALSPAC were modest, and the extent to which these reflect the 
same underlying construct is unclear. Thus, the questionnaire findings do not represent an 
internal replication. Further, after correction for multiple testing, although the associations 
between social understanding, intelligibility/fluency, irritability and headstrong behavior and 
schizophrenia PRS were significant, they represent only weak evidence of an association with 
the outcome. 
However, we provide novel evidence that certain pre-pubertal features found to be 
antecedents to schizophrenia index genetic liability and highlight the importance of further 
investigating these features at a very early age in high-risk groups. Future investigation into 
the robustness of specific findings will be important and our population findings provide 
specific hypotheses to now test in high-risk longitudinal samples. 
Another limitation is that our target sample is a longitudinal birth cohort study that inevitably 
faces issues of non-random attrition. This likely resulted in a retained sample with lower PRS 
and fewer developmental impairments - which may have resulted in underestimated 
associations between PRS and pre-pubertal characteristics. Finally, although PRS provide a 
useful indicator of genetic liability (see 23), they are not a recommended method for 
explaining a substantial amount of phenotype variance of population traits that may only be 
weakly correlated with risk of disorder – indeed, schizophrenia PRS only explain a small 
amount of the variance in childhood neurodevelopment in our analyses and some associations 
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did not remain when controlling for social class, although schizophrenia PRS were not 
associated with social class. The effect sizes of our associations are small but typical for this 
kind of work using PRS (e.g. 7, 22). 
 
The present study indicates that for schizophrenia liability such characteristics may be present 
as early as age 4 years old. An important future research goal would be to distinguish 
between early manifestations of liability that reflect pleiotropy and those that represent 
developmental impairments that are causally associated with schizophrenia. Intervention 
studies are likely to be useful here.  Pleiotropic effects may provide insight into cross-
diagnostic nosology and trans-diagnostic processes (28), while causal factors may help to 
inform interventions that promote resilience to future impairment (29). 
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Table 1. Associations between schizophrenia polygenic risk scores (PRS) and phenotypic 
variables at age 7-9 
 Continuous outcomes Dichotomized outcomes# 
 β SE FDR 
adjusted p 
R2 OR (95% CI) 
Cognition/learning      
  Inattention 0·012 0·013 0·46 <0·001 1·01             (0·96-1·07) 
  Reading -0·017 0·013 0·26 <0·001 1·04 (0·96-1·14) 
  Verbal IQ -0·020 0·013 0·24 <0·001 1·05 (0·96-1·15) 
  Performance IQ -0·056 0·013 0·00034 0·003 1·13 (1·04-1·23) 
Social/communication      
  Social understanding -0·032 0·013 0·043 0·001 1·08 (1·00-1·17) 
  Intelligibility/fluency -0·032 0·013 0·043 0·001 1·10 (1·02-1·20) 
  Pragmatic language -0·003 0·013 0·82 <0·001 0·97 (0·89-1·06) 
Emotion/mood 
regulation 
    
  Irritability 0·032 0·013 0·043 0·001 1·07 (1·01-1·14) 
  Anxiety 0·022 0·014 0·22 0·001 1·02 (0·97-1·08) 
Behavior      
  Headstrong 0·031 0·013 0·043 0·001 1·08 (1·02-1·15) 
  Aggression 0·016 0·013 0·28 <0·001 1·06 (0·98-1·16) 
  Activity/impulsivity 0·004 0·013 0·82 <0·001 1·01 (0·96-1·06) 
Highlighted where there is evidence of an association. FDR = false discovery rate # ≥1 
symptom for DAWBA, bottom 10% of distribution for reading, IQ, and 
social/communication variables. 
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Table 2. Associations between schizophrenia polygenic risk scores and SDQ subscales at age 
4 years 
 Continuous outcomes Dichotomized outcomes# 
 β SE p R2 OR (95% CI) 
Social/communication       
  Prosocial behavior -0·031 0·013 0·012 0·001 1·05 (0·97-1·15) 
Emotion/mood regulation      
  Emotional problems  0·021 0·013 0·12 <0·001 1·01 (0·93-1·10) 
  Irritability 0·021 0·013 0·11 <0·001 1·04 (0·96-1·11) 
Behavior       
  Conduct problems 0·026 0·013 0·046 0·001 1·08 (0·99-1·18) 
# Bottom 10% of distribution for prosocial behavior; top 10% for emotional problems, 
irritability and conduct problems. 
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Supplementary material 
ALSPAC data 
In total 9912 ALSPAC children were genotyped, of whom 8365 passed quality control. Full genotyping details 
and individual exclusion criteria are described elsewhere (1). Known autosomal variants were imputed with 
MACH 1.0.16 Markov Chain Haplotyping software (2, 3) using CEPH individuals from phase 2 of the HapMap 
project (HG18) as a reference set (release 22) resulting in a total N=2,543,887 SNPs. Dosage data were 
transformed from MACH output to PLINK format using fcGENE (4). After quality control exclusions (call rate 
<95%, MAF <1%, HWE P>5x10-7, R2≥0·7) there were 1,813,169 autosomal SNPs. The ALSPAC team used 
EIGENSTRAT principal components analysis to generate the top 100 components after the removal of known 
regions of long linkage disequilibrium in the data (5, 6). EIGENSTRAT analysis revealed no additional obvious 
population stratification and genome-wide analyses with other phenotypes indicated a low lambda. In-line with 
previous work (14) we did not include principal components in our main analyses, but ran a sensitivity analyses 
including the top 10 EIGENSTRAT principal components, as has been done previously (7). These are presented 
in Supplementary Table 6. Individuals with genetic data who were alive at one year were included in this study 
(N=8125).  
Both genetic and phenotypic data were available for N=55253-6157 children depending on the phenotypic 
variable and age. 
The Strengths and Difficulties Questionnaire (SDQ) 
The SDQ subscales were generated using the items presented below (8). For conduct problems, we excluded the 
irritability item ‘often has temper tantrums or hot tempers’, which is traditionally included in this subscale, as 
we consider this a dimension of emotion/mood regulation. Prosocial behavior: considerate of other people's 
feelings; shares readily with other children; helpful if someone is hurt; kind to younger children; often 
volunteers to help others. Emotional problems: often complains of headaches; many worries; often unhappy, 
downhearted; nervous or clingy in new situations; many fears, easily scared. Conduct problems: generally 
obedient (reverse coded); often fights with other children; often lies and cheats; steals from home, school or 
elsewhere. Irritability item: often has temper tantrums or hot tempers. 
Generating polygenic risk scores 
Schizophrenia risk alleles were identified from the Psychiatric Genetic Consortium (PGC) meta-analysis of 
case-control GWAS of schizophrenia (35,476 cases and 46,839 controls) (12). PGC SNPs were limited to those 
that passed an imputation quality control threshold akin to that set for the target sample (INFO score >=0·7). 
Autosomal SNPs that were present in both the target and discovery sample were limited to those in relative 
linkage equilibrium using the --clump command in PLINK (13). SNPs were strand-flipped where appropriate so 
that the ALSPAC and PGC SNP were strand aligned. In-line with previous work (14), SNPs were clumped with 
an R2 threshold of 0·25 and a distance threshold of 500kb, retaining SNPs with the lowest association p-value - 
only a single SNP within the extended major histocompatibility complex (MHC; chromosome 6: 25-34Mb) was 
included due to the high linkage disequilibrium (LD) within this region. While clumped results are available 
from the PGC, in these data the retained SNPs in each ‘clump’ are not necessarily those present in ALSPAC. 
We therefore ran our own clumping to maximize the number of SNPs included in the polygenic risk scores, 
which resulted in 185,051 clumped SNPs. These were used to generate polygenic risk scores using the --score 
command. Scores were calculated as the mean number of risk alleles weighted by effect size (log odds ratio). 
Polygenic risk scores were standardized using Z-score transformation.
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Table S1. Means, standard deviations, and correlations between primary phenotype data 
 
Primary variables Descriptives Correlations 
 Mean  (SD) %#  (N) 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 
1. Inattention 2·47  (3·70) 51·4 (2905) 1            
2. Reading 0·02  (0·99) 9·8 (589) -0·25 1           
3. Verbal IQ 0·05  (1·00) 10·5 (580) -0·19 0·57 1          
4. Performance IQ 0·04  (0·99) 9·5 (526) -0·19 0·35 0·49 1         
5. Social understanding 7·15 (1·43)  12.3 (2123) -0·43 0·13 0·10 0·09 1        
6. Intelligibility/fluency 35·30 (1·89) 11·1 (640) -0·22 0·26 0·20 0·12 0·16 1       
7. Pragmatic language 150·87  (7·74) 10·4 (586) -0·48 0·26 0·25 0·21 0·42 0·35 1      
8. Irritability 0·49  (1·08) 24·2 (1358) 0·41 -0·07 -0·05 -0·05 -0·39 -0·10 -0·30 1     
9. Anxiety 0·96  (1·70) 34·5 (1950) 0·23 0·02 0·02 -0·02 -0·14 -0·03 -0·18 0·30 1    
10. Headstrong 0·74  (1·51) 29·1 (1644) 0·48 -0·11 -0·07 -0·08 -0·45 -0·08 -0·34 0·76 0·23 1   
11. Aggression 0·13  (0·45) 9·8 (545) 0·24 -0·11 -0·09 -0·06 -0·27 -0·07 -0·21 0·34 0·12 0·36 1  
12. Activity/impulsivity 2·41 (3·58) 52·9 (2992) 0·71 -0·21 -0·14 -0·14 -0·46 -0·15 -0·50 0·47 0·21 0·59 0·31 1 
Between-variable correlations N=4539-5631, for individual variables N=5525-6037. #Used to generate odds ratios for dichotomized outcomes (≥1 symptom for DAWBA, 
bottom 10% of distribution for reading, IQ and social/communication variables, in-line with previous work (e.g. 14)). 
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Table S2. Means, standard deviations, and correlations between secondary phenotype data (SDQ) 
 
 Age 4 Age 7 
 1. 2. 3. 4. 1. 2. 3. 4. 
1. Prosocial behavior 1    1    
2. Emotional problems  -0·11 1     -0·13 1     
3. Irritability -0·21 0·22 1  -0·23 0·25 1  
4. Conduct problems -0·36 0·20 0·35 1 -0·41 0·22 0·39 1 
Mean  7·06 1·45 0·82 1·11 8·19 1·50 0·59 0·99 
(SD) (1.97) (1.52) (0.67) (1.01) (1.75) (1.66) (0.68) (1.03) 
Between-variable correlations N=6134-6143 and 5702-5707 for age 4 and age 7 respectively. For individual 
variables N=6143-6157 and 5716-5737 respectively. 
 
 
Table S3. Correlations between primary dimensions and secondary questionnaire (SDQ) measure (age 7) 
 
Primary dimension (domain) Prosocial behavior Emotional problems Irritability Conduct problems 
Social understanding  
(social/communication) 0.32 -0·16 -0·23 -0·32 
Irritability  
(emotion/mood regulation) -0·25 0·23 0·37 0·34 
Headstrong  
(behavior) -0·28 0·18 0·33 0·43 
N=5048-5109. Primary dimensions included where primary analyses found evidence of association with 
schizophrenia polygenic risk scores and where a secondary measure of the same domain was available (i.e. 
performance IQ and intelligibility/fluency were not included as there was no secondary measures of cognition 
and communication). 
 
Table S4. Associations between schizophrenia polygenic risk scores and SDQ subscales at age 7 years 
 
                 Continuous outcomes Dichotomized outcomes# 
 β SE p R2 OR (95% CI) 
Social/communication       
  Prosocial behavior -0·036 0·014 0·0083 0·001 1·14 (1·04-1·24) 
Emotion/mood regulation       
  Emotional problems  0·027 0·013 0·043 0·001 1·10 (1·01-1·18) 
  Irritability 0·030 0·013 0·024 0·001 1·12 (1·03-1·21) 
Behavior       
  Conduct problems 0·035 0·013 0·0084 0·001 1·05 (0·95-1·16) 
# Bottom 10% of distribution for prosocial behavior; top 10% for emotional problems, irritability and conduct 
problems. 
 
Table S5. Associations between schizophrenia polygenic risk scores and phenotypic variables at age 7-9, 
controlling for child gender and parental income 
 
                 Continuous outcomes Dichotomized outcomes# 
 β SE p OR (95% CI) 
Cognition/learning      
  Inattention -0·001 0·015 0·96 1·00 (0·94-1·07) 
  Reading -0·020 0·015 0·19 1·11 (1·00-1·24) 
  Verbal IQ -0·007 0·015 0·63 1·04 (0·93-1·15) 
  Performance IQ -0·046 0·016 0·0032 1·11 (1·00-1·24) 
Social/communication      
  Social understanding -0·026 0·016 0·10 1·05 (0·98-1·12) 
  Intelligibility/fluency -0·032 0·015 0·031 1·11 (1·01-1·23) 
  Pragmatic language 0·004 0·015 0·81 0·96 (0·86-1·06) 
Emotion/mood regulation      
  Irritability 0·021 0·015 0·18 1·06 (0·99-1·14) 
  Anxiety 0·017 0·017 0·33 1·00 (0·94-1·07) 
Behavior      
  Headstrong 0·034 0·015 0·023 1·10 (1·03-1·18) 
  Aggression 0·003 0·015 0·84 1·03 (0·93-1·14) 
  Activity/impulsivity 0·000 0·015 0·99 1·00 (0·94-1·07) 
Gender coded 0=female, 1=male, income assessed as the average household income band, including social 
benefits, each week when the child was on a ten-point scale when the child was 134 months old. Schizophrenia 
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PRS was not associated with sex (OR=1.02, 95% CI = 0.98-1.06, p=0.41) or income (OR=1.02, 95% CI = 0.97-
1.08, p=0.38) # ≥1 symptom for DAWBA, bottom 10% of distribution for reading, IQ, and 
social/communication variables.  
Table S6. Associations between schizophrenia polygenic risk scores and phenotypic variables at age 7-9, 
controlling for 10 EIGENSTRAT population stratification covariates 
 
                 Continuous outcomes Dichotomized outcomes# 
 β SE p OR (95% CI) 
Cognition/learning      
  Inattention 0·013 0·013 0·34 1·01 (0·96-1·07) 
  Reading -0·019 0·013 0·15 1·05 (0·96-1·14) 
  Verbal IQ -0·021 0·013 0·12 1·05 (0·96-1·15) 
  Performance IQ -0·056 0·013 <0·0001 1·13 (1·04-1·23) 
Social/communication      
  Social understanding -0·032 0·013 0·016 1·09 (1·00-1·18) 
  Intelligibility/fluency -0·032 0·013 0·014 1·11 (1·02-1·20) 
  Pragmatic language -0·004 0·013 0·79 0·97 (0·89-1·06) 
Emotion/mood regulation      
  Irritability 0·032 0·013 0·014 1·08 (1·01-1·14) 
  Anxiety 0·023 0·014 0·10 1·02 (0·97-1·08) 
Behavior      
  Headstrong 0·032 0·013 0·011 1·09 (1·03-1·15) 
  Aggression 0·016 0·013 0·20 1·06 (0·98-1·16) 
  Activity/impulsivity 0·005 0·013 0·71 1·01 (0·96-1·06) 
# ≥1 symptom for DAWBA, bottom 10% of distribution for reading, IQ, and social/communication variables.  
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Figure S1. Associations between schizophrenia polygenic risk scores and phenotypic variables at age 7-9, using 
a range of p-value thresholds from the discovery sample 
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